Table 2. Blood pressure levels in patients with AR: comparison between MFNS1 a before and after treatment.
| Variable | Mean value before treatment (mmHg) | Mean value after treatment (mmHg) | p value |
|---|---|---|---|
| Average systolic BP at daytime All patients Male Female |
120 ± 9.1 122 ± 8.6 112 ± 6.2 |
117 ± 9.4 119 ± 7.7 110 ± 12.2 |
0.024 0.016 0.638 |
| Average diastolic BP at daytime All patients Male Female |
73 ± 5.5 74 ± 5.7 71 ± 3.7 |
71 ± 7.4 72 ± 7.2 70 ± 8.7 |
0.027 0.009 0.874 |
| Average systolic BP at nighttime | 109 ± 8.4 | 107 ± 10.3 | 0.182 |
| Average diastolic BP at nighttime | 65 ± 6.4 | 65 ± 9.3 | 0.944 |
| Average BP at daytime All patients Male Female |
86 ± 5.7 86 ± 5.7 82 ± 4.7 |
83 ± 7.6 83 ± 7.0 82 ± 9.9 |
0.007 0.003 0.910 |
| Average BP at nighttime | 77 ± 8.0 | 73 ± 16.2 | 0.116 |
BP: blood pressure; MFNS: mometasone furoate nasal spray. 1Data are presented as mean ± SD